Search
for
Sort by
Research 31–60 of 248
- Multisystemic eosinophilic epitheliotropic disease in a horse
- Symptoms of Chronic Ketosis in Cows and Morphobiochemical Indicators of Blood
- Clinico-Pathological Profile of Cutaneous Lupus Erythematosus Patients: A Report from A Tertiary Care Center of Chattogram
- Medications
- The difficulty of finding ‘healthy’ volunteers
- Severe cutaneous adverse reactions to drugs
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- COVID-19 and Sex Differences
- Lupus erythematosus: systemic and cutaneous manifestations
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Graft-versus-host disease
- Paraneoplastic alopecia associated with internal malignancies in the cat
- TOXIC EPIDERMAL NECROLYSIS
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Toward a Diagnostic Score in Cushing's Syndrome
- Update on the dermatologic use of systemic glucocorticosteroids
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
- FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches
- The Clinical Presentation of Systemic Lupus Erythematosus
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations